Băetu Alexandru Emil, Mirea Liliana Elena, Cobilinschi Cristian, Grințescu Ioana Cristina, Grințescu Ioana Marina
Department of Anesthesiology and Intensive Care II, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Department of Anesthesiology and Intensive Care, Grigore Alexandrescu Clinical Emergency Hospital for Children, 011743 Bucharest, Romania.
J Pers Med. 2024 Dec 21;14(12):1168. doi: 10.3390/jpm14121168.
: Blunt thoracic trauma possesses unique physiopathological traits due to the complex interaction of immune and coagulation systems in the lung tissue. Hemogram-based ratios such as neutrophil-to-lymphocyte (NLR), platelet-to-lymphocyte (PLR), neutrophil-to-lymphocyte × platelet (NLPR) ratios have been studied as proxies for immune dysregulation and survival in trauma. We hypothesized that blunt thoracic trauma patients exhibit distinct patterns of coagulation and inflammation abnormalities identifiable by the use of readily available hemogram-derived markers. : The present study represents a retrospective observational analysis that included 86 patients with blunt thoracic trauma from a single high-volume level one trauma center. The primary outcome was mortality prediction in blunt thoracic trauma patients using these derived biomarkers. Secondary outcomes included phenotypes of the immune response and coagulopathy and the prediction of non-fatal adverse events. : A U-shaped distribution of mortality was found, with high rates of early deaths in patients with an NLPR value of <3.1 and high rates of late deaths in patients with NLPR > 9.5. A subgroup of blunt thoracic trauma patients expressing moderate inflammation and inflammation-induced hypercoagulation objectified as NLPR between 3.1 and 9.5 may have a survival benefit ( < 0.0001). The NLPR cut-off for predicting early deaths and the need for massive transfusion was 3.1 (sensitivity = 80.00% and specificity = 71.05%). : These findings suggest that blunt thoracic trauma patients exhibit distinct phenotypes of the immune response and coagulopathy from the early stages. A controlled, balanced interaction of immune, coagulation, and fibrinolytic systems might effectively achieve tissue repair and increase survival in thoracic trauma patients and should be subject to further research.
钝性胸部创伤由于肺组织中免疫和凝血系统的复杂相互作用而具有独特的生理病理特征。基于血常规的比率,如中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、中性粒细胞与淋巴细胞×血小板比值(NLPR),已被作为创伤中免疫失调和生存的替代指标进行研究。我们假设钝性胸部创伤患者表现出可通过使用易于获得的血常规衍生标志物识别的独特凝血和炎症异常模式。
本研究是一项回顾性观察分析,纳入了来自单个高容量一级创伤中心的86例钝性胸部创伤患者。主要结局是使用这些衍生生物标志物预测钝性胸部创伤患者的死亡率。次要结局包括免疫反应和凝血病的表型以及非致命不良事件的预测。
发现死亡率呈U形分布,NLPR值<3.1的患者早期死亡率高,NLPR>9.5的患者晚期死亡率高。NLPR在3.1至9.5之间的一组表现为中度炎症和炎症诱导的高凝状态的钝性胸部创伤患者可能具有生存优势(<0.0001)。预测早期死亡和大量输血需求的NLPR临界值为3.1(敏感性=80.00%,特异性=71.05%)。
这些发现表明,钝性胸部创伤患者从早期就表现出独特的免疫反应和凝血病表型。免疫、凝血和纤溶系统的可控、平衡相互作用可能有效地实现组织修复并提高胸部创伤患者的生存率,值得进一步研究。